Summit Therapeutics
SMMT
SMMT
11 hedge funds and large institutions have $23.1M invested in Summit Therapeutics in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$815K | |
| 2 | +$101K | |
| 3 | +$31.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.85K |
Top Sellers
| 1 | -$761K | |
| 2 | -$428K | |
| 3 | -$20.3K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11K |
| 5 |
JCM
Jacobi Capital Management
Pittston,
Pennsylvania
|
-$7K |